Promising Results from Phase 2 Clinical Trial
Phase 2 clinical trials represent a critical juncture in the drug development process, serving as a bridge between the initial safety assessments conducted in Phase 1 and the more extensive efficacy evaluations of Phase 3 trials. These trials typically involve a larger group of participants, often ranging from 100 to 300 individuals, who have the […]
Promising Results from Phase 2 Clinical Trial Read More »










